27 April 2025 : Clinical Research
Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in Tianjin, China
Jingyi Wang12BCDEF, Zhida Wang12ABG, Bei Sun12FG, Liming Chen
12AG*
DOI: 10.12659/MSM.947450
Med Sci Monit 2025; 31:e947450
Figure 1 Baseline laboratory values by vaccination group. Baseline levels of key clinical biomarkers in diabetic patients are presented, stratified by COVID-19 vaccination status: Group A (unvaccinated), Group B (primary immunization), and Group C (booster immunization). Significance levels annotated as *** p<0.001, ** p<0.01, * p<0.05, and “ns” indicating non-significant differences.